Orthogonal Techniques in Biologic Development: Advancing Precision with Almac’s Expertise

As biologic therapies continue to revolutionise modern medicine, their complexity demands increasingly sophisticated analytical strategies. Unlike small molecules, biologics are large, heterogeneous, and sensitive to manufacturing conditions. This makes their characterisation and quality assurance particularly challenging.

To address this, the industry has embraced orthogonal techniques—independent, complementary analytical methods used to evaluate the same critical quality attribute (CQA).

In this Almac Voice, Almac Sciences Business Development Manager, Philip Nicholl discusses Orthogonal Techniques in Biologic Development: Advancing Precision with Almac’s Expertise.